These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 23451912)

  • 1. Pseudoporphyria induced by imatinib mesylate.
    Pérez NO; Esturo SV; Viladomiu Edel A; Moreno AJ; Valls AT
    Int J Dermatol; 2014 Feb; 53(2):e143-4. PubMed ID: 23451912
    [No Abstract]   [Full Text] [Related]  

  • 2. Imatinib mesylate-induced pseudoporphyria in two children.
    Mahon C; Purvis D; Laughton S; Bradbeer P; Teague L
    Pediatr Dermatol; 2014; 31(5):603-7. PubMed ID: 24920470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A patient of chronic myelogenous leukemia developing painful rash on feet.
    Kumar P; Das NK; Sil A; Chakrabarti P
    J Postgrad Med; 2012; 58(4):331-4. PubMed ID: 23298941
    [No Abstract]   [Full Text] [Related]  

  • 4. Skin fragility and blistering with imatinib mesylate.
    Verma SM; Murphy G
    J Eur Acad Dermatol Venereol; 2010 Apr; 24(4):496-8. PubMed ID: 19925597
    [No Abstract]   [Full Text] [Related]  

  • 5. Photosensitization in chronic myelogenous leukaemia patients treated with imatinib mesylate.
    Rousselot P; Larghero J; Raffoux E; Calvo F; Tulliez M; Giraudier S; Rybojad M
    Br J Haematol; 2003 Mar; 120(6):1091-2. PubMed ID: 12648085
    [No Abstract]   [Full Text] [Related]  

  • 6. Imatinib mesylate induced erythroderma.
    Sanghavi SA; Dongre AM; Khopkar US
    Indian J Dermatol Venereol Leprol; 2012; 78(3):408. PubMed ID: 22565463
    [No Abstract]   [Full Text] [Related]  

  • 7. Multiple skin lesions caused by imatinib mesylate treatment of chronic myeloid leukemia.
    Machaczka M; Gossart M
    Pol Arch Med Wewn; 2013; 123(5):251-2. PubMed ID: 23722191
    [No Abstract]   [Full Text] [Related]  

  • 8. Imatinib mesylate causes palmoplantar hyperkeratosis and nail dystrophy in three patients with chronic myeloid leukaemia.
    Deguchi N; Kawamura T; Shimizu A; Kitamura R; Yanagi M; Shibagaki N; Matsue H; Shimada S
    Br J Dermatol; 2006 Jun; 154(6):1216-8. PubMed ID: 16704666
    [No Abstract]   [Full Text] [Related]  

  • 9. Trachyonychia in a patient with chronic myeloid leukaemia after imatinib mesylate.
    Lau YM; Lam YK; Leung KH; Lin SY
    Hong Kong Med J; 2014 Oct; 20(5):464.e2. PubMed ID: 25307080
    [No Abstract]   [Full Text] [Related]  

  • 10. Imatinib mesylate-induced neutrophilic folliculitis in a teenager.
    García-Romero MT; Durán-McKinster C; de Ocariz MS; Carrasco-Daza D; Palacios-López C; Orozco-Covarrubias L; Ruiz-Maldonado R
    Int J Dermatol; 2012 Dec; 51(12):1529-30. PubMed ID: 22486540
    [No Abstract]   [Full Text] [Related]  

  • 11. Heliotrope-like eruption mimicking dermatomyositis in a patient treated with imatinib mesylate for chronic myeloid leukemia.
    Kuwano Y; Asahina A; Watanabe R; Fujimoto M; Ihn H; Tamaki K
    Int J Dermatol; 2006 Oct; 45(10):1249-51. PubMed ID: 17040457
    [No Abstract]   [Full Text] [Related]  

  • 12. Skin fragility and blistering secondary to imatinib.
    Reddy H; Horne HL; Maung Z
    Clin Exp Dermatol; 2012 Jul; 37(5):572-3. PubMed ID: 22224491
    [No Abstract]   [Full Text] [Related]  

  • 13. Follicular mucinosis associated with imatinib (STI571).
    Yanagi T; Sawamura D; Shimizu H
    Br J Dermatol; 2004 Dec; 151(6):1276-8. PubMed ID: 15606531
    [No Abstract]   [Full Text] [Related]  

  • 14. Imatinib mesylate-induced pseudoporphyria.
    Berghoff AT; English JC
    J Am Acad Dermatol; 2010 Jul; 63(1):e14-6. PubMed ID: 20542169
    [No Abstract]   [Full Text] [Related]  

  • 15. Imatinib-induced aplastic anemia in a patient with chronic myeloid leukemia.
    Mabed M; Elhefni AM; Damnhouri G
    Leuk Lymphoma; 2012 Nov; 53(11):2310-1. PubMed ID: 22462614
    [No Abstract]   [Full Text] [Related]  

  • 16. Pityriasis rosea associated with imatinib (STI571, Gleevec).
    Konstantopoulos K; Papadogianni A; Dimopoulou M; Kourelis C; Meletis J
    Dermatology; 2002; 205(2):172-3. PubMed ID: 12218236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oral lichenoid eruption associated with imatinib treatment.
    Gómez Fernández C; Sendagorta Cudós E; Casado Verrier B; Feito Rodríguez M; Suárez Aguado J; Vidaurrázaga Díaz de Arcaya C
    Eur J Dermatol; 2010; 20(1):127-8. PubMed ID: 19825526
    [No Abstract]   [Full Text] [Related]  

  • 18. Imatinib-induced erythroderma mediated by an unusual non-dose-dependent mechanism.
    Vano-Galvan S; Fernandez-Guarino M; Henriquez-Santana A; De Las Heras E; Calbacho M; Jaen P
    Eur J Dermatol; 2007; 17(6):538-9. PubMed ID: 17951138
    [No Abstract]   [Full Text] [Related]  

  • 19. [Imatinib plasma levels in the management of cutaneous side effects induced by imatinib (Glivec®): 2 case reports].
    Trabelsi S; Gaïes E; Sraïri S; Sahnoun R; Daghfous R; Lakhal M; El Aïdli S; Klouz A
    Ann Biol Clin (Paris); 2013; 71(2):203-6. PubMed ID: 23587588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Periungual pyogenic granuloma following imatinib therapy in a patient with chronic myelogenous leukemia.
    Dika E; Barisani A; Vaccari S; Fanti PA; Ismaili A; Patrizi A
    J Drugs Dermatol; 2013 May; 12(5):512-3. PubMed ID: 23652942
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.